China is the only major economy in the world not to approve or distribute COVID-19 vaccines that use the mRNA technology proven to be one of the most effective tools in preventing the spread of COVID-19. But China’s mRNA stance may be changing. On Thursday, Chinese media outlet Caixin reported that Chinese regulators had completed a review of the COVID-19 jab developed by German mRNA vaccine maker BioNTech and distributed locally via China’s Fosun Pharma. Fosun is still awaiting final approval from regulators, but, once approved, Fosun could deploy the 100 million doses it acquired from BioNTech last December to...